Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125050662 | 12505066 | 2 | F | 20160614 | 20160706 | 20160628 | 20160721 | EXP | US-GLAXOSMITHKLINE-US2016GSK091490 | GLAXOSMITHKLINE | 80.79 | YR | F | Y | 0.00000 | 20160721 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125050662 | 12505066 | 1 | PS | ZOVIRAX | ACYCLOVIR | 1 | Topical | UNK, PRN | AO94585 | 18603 | OINTMENT | ||||||||
| 125050662 | 12505066 | 2 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | UNK | 18603 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125050662 | 12505066 | 1 | Herpes simplex |
| 125050662 | 12505066 | 2 | Herpes simplex |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125050662 | 12505066 | Expired product administered | |
| 125050662 | 12505066 | No adverse event | |
| 125050662 | 12505066 | Vulvovaginal burning sensation | |
| 125050662 | 12505066 | Vulvovaginal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |